 |
PDBsum entry 6p4z
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone
|
 |
|
Title:
|
 |
Structure of gadolinium-caged cobalt (iii) insulin hexamer
|
|
Structure:
|
 |
Insulin chain a. Chain: a, c. Engineered: yes. Insulin chain b. Chain: b, d. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ins. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.184
|
R-free:
|
0.239
|
|
|
Authors:
|
 |
T.H.Tran,S.K.Taylor,M.N.Stojanovic,L.Tong
|
|
Key ref:
|
 |
S.K.Taylor
et al.
(2018).
Insulin Hexamer-Caged Gadolinium Ion as MRI Contrast-o-phore.
Chemistry,
24,
10646-10652.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
29-May-19
|
Release date:
|
12-Jun-19
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01308
(INS_HUMAN) -
Insulin from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
110 a.a.
21 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chemistry
24:10646-10652
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Insulin Hexamer-Caged Gadolinium Ion as MRI Contrast-o-phore.
|
|
S.K.Taylor,
T.H.Tran,
M.Z.Liu,
P.E.Harris,
Y.Sun,
S.R.Jambawalikar,
L.Tong,
M.N.Stojanovic.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
High-relaxivity protein-complexes of GdIII are being pursued as MRI
contrast agents in hope that they can be used at much lower doses that would
minimize toxic-side effects of GdIII release from traditional
contrast agents. We construct here a new type of protein-based MRI contrast
agent, a proteinaceous cage based on a stable insulin hexamer in which
GdIII is captured inside a water filled cavity. The macromolecular
structure and the large number of "free" GdIII coordination
sites available for water binding lead to exceptionally high relaxivities per
one GdIII ion. The GdIII slowly diffuses out of this cage,
but this diffusion can be prevented by addition of ligands that bind to the
hexamer. The ligands that trigger structural changes in the hexamer,
SCN- , Cl- and phenols, modulate relaxivities through an
outside-in signaling that is allosterically transduced through the protein cage.
Contrast-o-phores based on protein-caged metal ions have potential to become
clinical contrast agents with environmentally-sensitive properties.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |